The Rising Demand for Obesity Intervention Devices Market: Overview and Future Trends

PORTLAND, OR, UNITED STATES, February 18, 2025 /EINPresswire.com/ -- Market Overview

The global obesity intervention devices market is witnessing substantial growth, driven by the rising prevalence of obesity and related health complications. The market, valued at $243.2 million in 2021, is projected to reach $407.6 million by 2031, expanding at a CAGR of 5.3% from 2022 to 2031.
Obesity intervention devices, including gastric bands, gastric balloons, and gastric stimulator systems, are designed to aid weight management by reducing food intake or altering metabolic processes. These devices are proving highly effective, particularly in addressing obesity-related conditions such as type 2 diabetes.

Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/5480

Key Market Growth Drivers
Several factors contribute to the expanding obesity intervention devices market:
• Increasing Global Obesity Rates
• Over 1 billion people worldwide are affected by obesity.
• By 2030, 1 in 5 women and 1 in 7 men are projected to be obese.
• In the U.S., obesity prevalence rose from 36% in 2020 to 41% in 2021.
• Rising Cases of Type 2 Diabetes
• As of 2021, 537 million adults worldwide had type 2 diabetes, a number expected to surge to 783 million by 2045.
• Devices like LAP-BAND AP have shown potential in improving or even remitting type 2 diabetes in patients with BMI ≥ 35.
• Growing Awareness of Obesity-Related Risks
• Obesity is linked to chronic illnesses such as heart disease, stroke, and cancer.
• In India, a 550% surge in obesity-related queries was reported by Practo in 2020.
• Technological Advancements & New Product Launches
• Companies such as ReShape Lifesciences and Allurion Technologies are pioneering innovative obesity intervention solutions.
• The market has witnessed increased regulatory approvals for new devices.

Market Challenges
Despite strong growth prospects, the market faces notable challenges:
• Side Effects & Complications
• Common adverse effects include nausea, vomiting, and abdominal pain.
• Severe complications, such as stomach lining erosion and infections, can discourage patient adoption.
• High Costs & Limited Accessibility
• The cost of procedures remains a significant barrier, particularly in low- and middle-income countries.

Market Segmentation
The obesity intervention devices market is segmented by device type, end user, and region:
By Device Type:
• Gastric Bands – Adjustable bands limiting food intake.
• Gastric Balloons – Silicone balloons filled with saline to reduce stomach capacity.
• Gastric Stimulator Systems – Stimulates stomach muscles to aid weight loss.
• The gastric balloon segment led the market in 2021 and is expected to grow at the fastest CAGR due to new product approvals.

By End User:
• Hospitals – The largest segment due to trained medical staff and higher patient admissions.
• Gastroenterology Clinics & Ambulatory Surgical Centers – Increasing adoption due to convenience and faster recovery times.

By Region:
• North America – Leads the market, driven by key players like Apollo Endosurgery and Johnson & Johnson.
• Asia-Pacific – Expected to grow rapidly due to increasing obesity rates and improving healthcare infrastructure.

Recent Developments & Key Players
The market is highly competitive, with key players focusing on innovation and strategic collaborations. Notable developments include:
• ReShape Lifesciences received FDA approval for its GIBI HD calibration tube in August 2022.
• Allurion Technologies introduced a swallowable gastric balloon that requires no endoscopy.
• Other key players include Apollo Endosurgery, GI Dynamics, Allergan, and Johnson & Johnson.

Future Outlook
The obesity intervention devices market is poised for sustained growth due to:
• Rising obesity prevalence, increasing the demand for weight management solutions.
• Advancements in minimally invasive technologies, attracting more patients.
• Expanding markets in Asia-Pacific and LAMEA, driven by healthcare improvements and greater awareness.

Key Takeaways
• The global market is projected to grow from $243.2 million in 2021 to $407.6 million by 2031.
• Gastric balloons are the fastest-growing segment due to increasing innovations.
• North America dominates the market, while Asia-Pacific is set for rapid expansion.
• Challenges such as high costs and side effects persist, but increasing awareness and technology improvements are expected to drive adoption.

As global obesity rates continue to rise, obesity intervention devices will play an increasingly vital role in weight management and disease prevention, offering hope for millions seeking effective treatment solutions.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/5480

David Correa
Allied Market Research
+ + 1 800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube